| Patents for C12Q 1 - Measuring or testing processes involving enzymes or micro-organisms; Compositions therefor; Processes of preparing such compositions (300,231) |
|---|
| 01/03/2002 | CA2413596A1 Cell lines and cell-based assays for identification of androgen receptor modulators |
| 01/03/2002 | CA2413547A1 B7-like molecules and uses thereof |
| 01/03/2002 | CA2413417A1 Selective androgen receptor modulators and methods for their identification, design and use |
| 01/03/2002 | CA2413209A1 Modulation of a.beta. levels by .beta.-secretase bace2 |
| 01/03/2002 | CA2412721A1 Methods and compositions for transcription-based nucleic acid amplification |
| 01/03/2002 | CA2412635A1 Novel proteases |
| 01/03/2002 | CA2412612A1 Eg-vegf nucleic acids and polypeptides and methods of use |
| 01/03/2002 | CA2412610A1 Gp286 nucleic acids and polypeptides |
| 01/03/2002 | CA2412256A1 Polynucleotides and polypeptides encoded thereby |
| 01/03/2002 | CA2411515A1 Generation of libraries of antibodies in yeast and uses thereof |
| 01/03/2002 | CA2410951A1 Multiply-primed amplification of nucleic acid sequences |
| 01/03/2002 | CA2409408A1 Modulation of chromosome function by chromatin remodeling agents |
| 01/03/2002 | CA2408424A1 Use of urokinase inhibitors for the treatment and/or prevention of pulmonary hypertension and/or cardiac remodelling |
| 01/03/2002 | CA2408326A1 Recombinant constructs and their use in reducing gene expression |
| 01/03/2002 | CA2381338A1 Human lyases |
| 01/03/2002 | CA2381241A1 Truncated egf receptor |
| 01/02/2002 | EP1167975A1 Compositions and methods for detecting, treating or predicting the response of tumor cells to endocrine therapy. |
| 01/02/2002 | EP1167972A2 Enzyme catalyzed therapeutic agents |
| 01/02/2002 | EP1167970A1 Method for quantitating leukocyte count in whole blood sample |
| 01/02/2002 | EP1167963A1 Biosensor |
| 01/02/2002 | EP1167544A2 Probe for diagnosing infectious disease arising from Escherichia coli, Klebsiella pneumoniae or Enterobacter cloacae |
| 01/02/2002 | EP1167543A2 Probe for diagnosing infectious disease arising from Staphylococcus epidermidis |
| 01/02/2002 | EP1167542A2 Probe for diagnosing infectious disease arising from Enterococcus faecalis |
| 01/02/2002 | EP1167541A2 Method for obtaining data for the preparation of a diagnosis of phakomatoses |
| 01/02/2002 | EP1167540A2 Dye couple for spectrophotometric determination of analytes |
| 01/02/2002 | EP1167539A1 Methods for identifying inhibitors of the anaphase promoting complex |
| 01/02/2002 | EP1167538A1 Biosensor and method for its production |
| 01/02/2002 | EP1167526A1 IgE-dependent histamine-releasing factor(HRF)receptor, HRF-binding peptides and nucleic acids encoding the same, and uses thereof |
| 01/02/2002 | EP1167524A1 Method for amplifying nucleic acid sequence |
| 01/02/2002 | EP1167522A1 Method for screening biomolecule activity regulator |
| 01/02/2002 | EP1167519A1 Glucose dehydrogenase |
| 01/02/2002 | EP1167386A1 Canine and feline melanocortin-4 receptor sequences and screening assays to identify compounds useful in regulating animal appetite and metabolic rate |
| 01/02/2002 | EP1167379A2 Immunomodulatory oligonucleotides |
| 01/02/2002 | EP1167378A2 Immunomodulatory oligonucleotides |
| 01/02/2002 | EP1167377A2 Immunomodulatory oligonucleotides |
| 01/02/2002 | EP1166797A1 Method of controlling the qualities of attenuated pox vaccine |
| 01/02/2002 | EP1166119A1 Homogeneous detection and/or determination method for a chemical or physico-chemical interaction |
| 01/02/2002 | EP1166118A1 Semiconductor nanocrystal probes for biological applications |
| 01/02/2002 | EP1166117A2 Diagnosis and treatment of multiple sclerosis |
| 01/02/2002 | EP1166116A1 Miniaturized cell array methods and apparatus for cell-based screening |
| 01/02/2002 | EP1166113A1 Lipopolysaccharide immunoassay and test device |
| 01/02/2002 | EP1166098A1 Automated 2-dimensional analysis of biological and other samples |
| 01/02/2002 | EP1166076A2 Snp detection |
| 01/02/2002 | EP1165842A1 Lentiviral vector system for high quantity screening |
| 01/02/2002 | EP1165841A1 Detection of nucleic acid amplified products |
| 01/02/2002 | EP1165840A1 Mutations associated with iron disorders |
| 01/02/2002 | EP1165839A2 Universal arrays |
| 01/02/2002 | EP1165838A2 Coupled polymerase chain reaction-restriction endonuclease digestion-ligase detection reaction process |
| 01/02/2002 | EP1165837A2 Method for mapping a dna molecule comprising an $i(ad infinitum) amplification step |
| 01/02/2002 | EP1165836A2 Schizophrenia associated genes, proteins and biallelic markers |
| 01/02/2002 | EP1165835A2 GENOMIC SEQUENCE OF THE $i(PURH) GENE AND $i(PURH)-RELATED BIALLELIC MARKERS |
| 01/02/2002 | EP1165834A1 High throughput screening method for determining enantioselectivity |
| 01/02/2002 | EP1165833A1 Methods and compositions using binding partners |
| 01/02/2002 | EP1165832A2 Novel method for identifying antibacterial compounds |
| 01/02/2002 | EP1165831A1 Chromogenic medium for detecting staphylococcus aureus |
| 01/02/2002 | EP1165828A1 50 human secreted proteins |
| 01/02/2002 | EP1165827A1 45 human secreted proteins |
| 01/02/2002 | EP1165824A1 Inefficient fast pcr |
| 01/02/2002 | EP1165815A1 Chimeric expression promoters originating from commelina yellow mottle virus and cassava vein mosaic virus |
| 01/02/2002 | EP1165813A2 Linear and circular expression elements |
| 01/02/2002 | EP1165812A2 Protozoan expression system |
| 01/02/2002 | EP1165809A2 Leukotriene b4 receptor transgenic mammals |
| 01/02/2002 | EP1165805A1 Dsp-2 dual-specificity map kinase phosphatase |
| 01/02/2002 | EP1165800A2 Mitomycin biosynthetic gene cluster |
| 01/02/2002 | EP1165795A2 Streptococcus pneumoniae antigens |
| 01/02/2002 | EP1165790A1 Protease activated receptor 2 variants |
| 01/02/2002 | EP1165789A2 Vesicle associated proteins |
| 01/02/2002 | EP1165788A2 Molecules of the immune system |
| 01/02/2002 | EP1165787A2 Isolated dna encoding cullin regulators roc1 and roc2, isolated proteins encoded by the same, and methods utilizing the same |
| 01/02/2002 | EP1165785A1 48 human secreted proteins |
| 01/02/2002 | EP1165784A2 Nucleic acids including open reading frames encoding polypeptides; "orfx" |
| 01/02/2002 | EP1165778A2 Casb618 polynucleotides and polypeptides and their use |
| 01/02/2002 | EP1165777A2 Genes encoding human potassium channel proteins |
| 01/02/2002 | EP1165774A2 Casb619 involved in colon cancers |
| 01/02/2002 | EP1165770A2 Methods for the identification and validation of functional intracellular targets with intramers or in vivo selection |
| 01/02/2002 | EP1165761A2 Methods for altering substrate specificity of phosphoinositide-dependent-protein kinase 1 (pdk1) |
| 01/02/2002 | EP1165755A1 Banana and melon promoters for expression of transgenes in plants |
| 01/02/2002 | EP1165750A1 Diagnosis of whipple disease |
| 01/02/2002 | EP1165745A1 Cell activity assay apparatus and methods for making and using same |
| 01/02/2002 | EP1165694A1 4,7-dichlororhodamine dyes useful as molecular probes |
| 01/02/2002 | EP1165616A1 Monoclonal antibodies, antigens and diagnosis and therapy of malignant diseases |
| 01/02/2002 | EP1165609A2 Human beta-secretase enzyme, inhibitors and their compositions and uses |
| 01/02/2002 | EP1165606A1 50 human secreted proteins |
| 01/02/2002 | EP1165604A2 Proteins related to neuronal regeneration and uses thereof |
| 01/02/2002 | EP1165603A1 Human neurogenin 3-encoding nucleotide sequences |
| 01/02/2002 | EP1165602A1 49 human secreted proteins |
| 01/02/2002 | EP1165597A1 Bifunctional molecules for delivery of therapeutics |
| 01/02/2002 | EP1165594A1 Antisense oligonucleotide modulation of stat3 expression |
| 01/02/2002 | EP1165592A1 INSECT p53 TUMOR SUPPRESSOR GENES AND PROTEINS |
| 01/02/2002 | EP1165591A1 47 human secreted proteins |
| 01/02/2002 | EP1165590A1 49 human secreted proteins |
| 01/02/2002 | EP1165587A1 50 human secreted proteins |
| 01/02/2002 | EP1165586A1 TCL-1b GENE AND PROTEIN AND RELATED METHODS AND COMPOSITIONS |
| 01/02/2002 | EP1165541A1 Dimeric compounds and as inhibitors of neuraminidase |
| 01/02/2002 | EP1165136A1 Combination therapy of angiotensin converting enzyme inhibitor and epoxy-steroidal aldosterone antagonist for treatment of cardiovascular disease |
| 01/02/2002 | EP1165135A1 Method of affecting cholesterol catabolism using nucear bile acid receptor |
| 01/02/2002 | EP1165133A1 Anti-human mitochondrial adenylate kinase isozyme antibody, diagnostic formulation and diagnostic kit for cardiac disease |
| 01/02/2002 | EP1165131A2 Attenuated dengue-1 virus vaccine |
| 01/02/2002 | EP1165124A1 Recombinant neospora antigens and their uses |
| 01/02/2002 | EP1165093A1 Method for validating/invalidating target(s) and pathways |